<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://pharmadevicenews.com/six-popular-sunscreen-ingredients-face-growing-scrutiny-cs-analytical-sees-a-testing-opportunity/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T13:04:50+00:00</news:publication_date>
      <news:title>Six popular sunscreen ingredients face growing scrutiny. CS Analytical sees a testing opportunity</news:title>
      <news:keywords>Avobenzone, Clifton, CS Analytical, Homosalate, Octinoxate, Octisalate, Octocrylene, Oxybenzone, Raw Material Analytical, United States Food and Drug Administration</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/eli-lilly-is-building-a-3-5bn-retatrutide-factory-why-will-patients-wait-until-2031/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T13:01:23+00:00</news:publication_date>
      <news:title>Eli Lilly is building a $3.5bn retatrutide factory. Why will patients wait until 2031?</news:title>
      <news:keywords>David Ricks, Edgardo Hernandez, Eli Lilly and Company, Fogelsville, Lehigh Valley, Mounjaro, Pennsylvania, retatrutide, Zepbound</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/braccos-new-ai-can-flag-brain-aneurysms-above-3-mm-can-it-improve-radiology-detection/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T12:57:18+00:00</news:publication_date>
      <news:title>Bracco’s new AI can flag brain aneurysms above 3 mm. Can it improve radiology detection?</news:title>
      <news:keywords>Avicenna.AI, Bracco Group, Bracco Imaging, CINA-Aneurysm, CINA-Aneurysm+, Radiological Society of North America, Subtle Medical, United States Food and Drug Administration, UPTUNITY</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/07/Median-Technologies-and-Olea-Medical-partner-to-commercialise-eyonis-LCS-lung-cancer-screening-AI-e1785513560404.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/htl-biotechnology-is-betting-e15m-on-salmon-derived-dna-can-regenerative-medicine-justify-the-expansion/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T12:54:10+00:00</news:publication_date>
      <news:title>HTL Biotechnology is betting €15m on salmon-derived DNA. Can regenerative medicine justify the expansion?</news:title>
      <news:keywords>Brittany, France, François Fournier, HTL Biotechnology, HTL Biotechnology Innovation, HTL8, Javené</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/05/AVLs-science-backed-skincare-push-raises-a-bigger-question-about-beauty-and-biotechnology-e1779025288209.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/novo-nordisk-cut-sickle-cell-crises-by-27-could-etavopivat-become-its-next-major-medicine/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15T12:50:39+00:00</news:publication_date>
      <news:title>Novo Nordisk cut sickle cell crises by 27%. Could etavopivat become its next major medicine?</news:title>
      <news:keywords>Etavopivat, European Medicines Agency, Forma Therapeutics, HIBISCUS, HIBISCUS2, Novo Nordisk, United States Food and Drug Administration</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/07/Laboratory-researchers-e1784822111116.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/why-the-boots-group-is-selling-farmacias-benavides-to-farmacias-del-ahorro/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:25:10+00:00</news:publication_date>
      <news:title>Why The Boots Group is selling Farmacias Benavides to Farmacias del Ahorro</news:title>
      <news:keywords>Comercializadora Farmacéutica de Chiapas, Comisión Nacional Antimonopolio, Farmacias Benavides, Farmacias del Ahorro, Grupo Farmacias del Ahorro, Mexico, Monterrey, Sycamore Partners, The Boots Group</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/ai-can-design-protein-binders-in-minutes-sino-biological-wants-to-validate-them-in-three-days/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:20:51+00:00</news:publication_date>
      <news:title>AI can design protein binders in minutes. Sino Biological wants to validate them in three days</news:title>
      <news:keywords>4RISE, Biacore, Carterra, Houston, Octet, Rob Burgess, Sino Biological, XPressMAX</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/molecular-designs-has-cleared-its-first-fda-hurdle-can-its-three-virus-pcr-panel-compete-on-workflow/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:17:31+00:00</news:publication_date>
      <news:title>Molecular Designs has cleared its first FDA hurdle. Can its three-virus PCR panel compete on workflow?</news:title>
      <news:keywords>Alabama, Birmingham, Greer Massey, Michael Clark, Molecular Designs, Simplicity Dx Extraction, SimplicityDx, United States Food and Drug Administration</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-14-2026-08_52_17-PM-e1789399378430.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/dana-farber-cut-cfdna-library-variability-to-8-could-this-solve-a-major-liquid-biopsy-bottleneck/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:13:27+00:00</news:publication_date>
      <news:title>Dana-Farber cut cfDNA library variability to 8%. Could this solve a major liquid biopsy bottleneck?</news:title>
      <news:keywords>AutoNorm, Dana-Farber Cancer Institute, icon96, iconPCR, Illumina, Integrated DNA Technologies, Molecular Biology Core Facilities, n6 Tec, Twist Bioscience, Zach Herbert</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/08/0673d3f2-195c-46f3-bb13-83b836d2eb34-e1787420428344.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/innovent-just-secured-seven-reimbursement-wins-in-china-can-mazdutide-deliver-its-next-growth-surge/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T07:10:30+00:00</news:publication_date>
      <news:title>Innovent just secured seven reimbursement wins in China. Can mazdutide deliver its next growth surge?</news:title>
      <news:keywords>China, Daiichi Sankyo, Eli Lilly and Company, Innovent Biologics, Jaypirca, mazdutide, PECONDLE, Picankibart, Sintbilo, TABOSUN, TYVYT, VANFLYTA</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-15-2026-09_17_45-AM-e1789444118165.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/could-routine-ob-gyn-visits-become-a-frontline-defence-against-heart-disease-unified-is-testing-the-idea/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:25:58+00:00</news:publication_date>
      <news:title>Could routine OB/GYN visits become a frontline defence against heart disease? Unified is testing the idea</news:title>
      <news:keywords>American Heart Association, Elizabeth Cherot, Florida, Go Red for Women Venture Fund, Lucina Analytics, Tampa, Tracy Warren, Unified Women&apos;s Healthcare</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/09/ChatGPT-Image-Sep-13-2026-10_25_46-AM-e1789275382436.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/imfinzis-new-bladder-cancer-regimen-cut-death-risk-by-42-can-astrazeneca-win-against-an-approved-rival/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:22:13+00:00</news:publication_date>
      <news:title>IMFINZI’s new bladder cancer regimen cut death risk by 42%. Can AstraZeneca win against an approved rival?</news:title>
      <news:keywords>Astellas Pharma, AstraZeneca, durvalumab, enfortumab vedotin, Imfinzi, Keytruda, Merck &amp; Co., PADCEV, Pfizer, United States Food and Drug Administration, VOLGA</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/08/PDN-tablets-generic-e1788149113473.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/zai-lab-just-secured-reimbursement-for-two-growth-medicines-can-2027-reverse-its-revenue-decline/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:18:29+00:00</news:publication_date>
      <news:title>Zai Lab just secured reimbursement for two growth medicines. Can 2027 reverse its revenue decline?</news:title>
      <news:keywords>argenx, AUGTYRO, Bristol Myers Squibb, China, KarXT, National Healthcare Security Administration, NUZYRA, QINLOCK, Vyvgart Hytrulo, Zai Lab</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/08/Schizophrenia-research-e1786477838518.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/ionis-reports-95-fewer-hae-attacks-after-two-years-can-dawnzera-defend-its-dosing-advantage/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:15:20+00:00</news:publication_date>
      <news:title>Ionis reports 95% fewer HAE attacks after two years. Can DAWNZERA defend its dosing advantage?</news:title>
      <news:keywords>American College of Allergy Asthma and Immunology, Dawnzera, donidalorsen, Ionis Pharmaceuticals, OASIS-HAE, OASISplus, United States Food and Drug Administration</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/08/Therapy-for-hereditary-angioedema-e1787681209572.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/drug-testing-has-been-stuck-with-paper-for-decades-did-i3collect-just-change-the-rules/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T06:11:41+00:00</news:publication_date>
      <news:title>Drug testing has been stuck with paper for decades. Did i3collect just change the rules?</news:title>
      <news:keywords>Desert Tox, i3collect, National Laboratory Certification Program, Premier Biotech, Substance Abuse and Mental Health Services Administration, United States Department of Transportation</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/clene-cut-a-six-week-als-data-task-to-one-week-can-faster-analysis-help-its-9-9m-cash-runway/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T04:01:22+00:00</news:publication_date>
      <news:title>Clene cut a six-week ALS data task to one week. Can faster analysis help its $9.9m cash runway?</news:title>
      <news:keywords>Clene Inc., Clene Nanomedicine, CNM-Au8, HEALEY ALS Platform Trial, InStat, RESCUE-ALS, RESTORE-ALS, United States Food and Drug Administration, Veristat</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/01/neurological-basis-of-amyotrophic-lateral-sclerosis.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/evidation-captured-1300-symptom-assessments-in-60-days-could-blood-sampling-finally-reveal-what-happens-during-autoimmune-flares/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T03:58:05+00:00</news:publication_date>
      <news:title>Evidation captured 1,300 symptom assessments in 60 days. Could blood sampling finally reveal what happens during autoimmune flares?</news:title>
      <news:keywords>Evidation, Leslie Oley Wilberforce, London Life Sciences Week, PACE, Precision in Autoimmune Condition Evidence, San Mateo, Sunny Khan</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/08/PDN-Diagnostics-2-generic.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/i2pure-says-conventional-iodine-strength-can-conceal-a-delivery-problem-what-does-the-chemistry-reveal/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T03:54:19+00:00</news:publication_date>
      <news:title>I2Pure says conventional iodine strength can conceal a delivery problem. What does the chemistry reveal?</news:title>
      <news:keywords>ACS Omega, American Chemical Society, Christopher Moses, I2Pure Corporation, Ilker Bayer, Jack Kessler, Maggie Engert</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/rocket-pharmaceuticals-has-an-approved-gene-therapy-and-279m-in-cash-can-it-deliver-on-both-fronts/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T03:51:41+00:00</news:publication_date>
      <news:title>Rocket Pharmaceuticals has an approved gene therapy and $279m in cash. Can it deliver on both fronts?</news:title>
      <news:keywords>European Medicines Agency, Hercules Capital, KRESLADI, Rocket Pharmaceuticals, RP-A501, RP-A601, RP-A701, United States Food and Drug Administration</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2026/04/biotech-research-technology-for-chronic-myeloid-leukemia-drug-development-e1777170361532.webp</image:loc>
    </image:image>
  </url>
  <url>
    <loc>https://pharmadevicenews.com/celanese-just-sold-another-19-of-nutrinova-for-152m-why-is-mitsui-taking-greater-control/</loc>
    <news:news>
      <news:publication>
        <news:name>PharmaDeviceNews</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14T03:48:04+00:00</news:publication_date>
      <news:title>Celanese just sold another 19% of Nutrinova for $152m. Why is Mitsui taking greater control?</news:title>
      <news:keywords>Celanese Corporation, Dallas, Frankfurt, Germany, Mitsui &amp; Co., Nutrinova Netherlands, Sunett</news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://pharmadevicenews.com/wp-content/uploads/2025/12/pharmadevicenews-1.png</image:loc>
    </image:image>
  </url>
</urlset>